Is it too late to buy Exact Sciences stock after Abbott's $21B deal?

Core Viewpoint - Exact Sciences experienced a nearly 20% increase in stock price on November 20 following the announcement of a $21 billion all-cash acquisition deal by Abbott Laboratories [1] Company Summary - Exact Sciences is a molecular diagnostics company that has attracted significant attention due to its acquisition by Abbott Laboratories [1] - Abbott Laboratories is set to acquire Exact Sciences for $21 billion in cash, indicating a strong interest in the molecular diagnostics sector [1]